First Time Loading...

Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 0.451 USD 4.57% Market Closed
Updated: May 2, 2024

Redhill Biopharma Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Redhill Biopharma Ltd
Net Income (Common) Peer Comparison

Comparables:
T
TEVA
TARO
I
INCR
MDWD
R
REKA

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Redhill Biopharma Ltd
NASDAQ:RDHL
Net Income (Common)
$23.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Net Income (Common)
-$559m
CAGR 3-Years
48%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Net Income (Common)
$45.6m
CAGR 3-Years
N/A
CAGR 5-Years
-32%
CAGR 10-Years
-18%
I
InterCure Ltd
TASE:INCR
Net Income (Common)
₪20.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-8%
Mediwound Ltd
NASDAQ:MDWD
Net Income (Common)
-$6.7m
CAGR 3-Years
10%
CAGR 5-Years
-45%
CAGR 10-Years
8%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Net Income (Common)
-₪8.4m
CAGR 3-Years
N/A
CAGR 5-Years
-62%
CAGR 10-Years
N/A

See Also

What is Redhill Biopharma Ltd's Net Income (Common)?
Net Income (Common)
23.9m USD

Based on the financial report for Dec 31, 2023, Redhill Biopharma Ltd's Net Income (Common) amounts to 23.9m USD.